|
John J. Cousins,
President , Treasurer, CFO, Controller and Director. Mr. Cousins holds undergraduate degrees from Boston University and the Lowell Institute School at MIT, and has an MBA from the Wharton School. He began his business career as a design engineer for Ampex Corporation, a manufacturer of broadcast and computer equipment, and the American Broadcasting Company television network. He was named vice president of Cimmaron Business Development Corporation, a southwest regional merchant and investment banking operation in 1990. In 1996, Mr. Cousins became president of Terra Firm, a business consulting firm. Since 1999, he has served as vice president, financial officer, and treasurer of Advanced Optics Electronics, Inc., a developmental stage technology company with a primary focus on the development, production and sales of large-scale flat panel displays. Advanced Optics Electronics, Inc., is a publicly traded company on the NASDAQ OTC Bulletin Board. Mr. Cousins has been president, treasurer, controller, and a director of Biomoda since 2002.
Leo Gomez,
Director of Research. Dr. Gomez holds a B.S. in Biology from the University of New Mexico, and an M.S. in Health Physics and a Ph.D. in Radiation Biology from Colorado State University. He has worked for Sandia, Los Alamos, and Oak Ridge National Labs, as well as for the Veterans Administration Hospital, Lovelace Foundation for Medical Education and Research, and the U.S. Department of Agriculture. With extensive experience in radiobiology, Dr. Gomez also collaborated with scientists in the former Soviet Union in developing and commercializing new radiopharmaceuticals and medical devices.
Constance Dorian,
Director of Technical Operations. Ms. Dorian earned a B.S. in Biology from San Diego State University. She has experience in the design and development of diagnostic assays, clinical studies, quality control, quality assurance, product support programs, product improvement programs, cost reduction programs, contract negotiations, inventory control, and production planning following FDA Guidelines.
Brett Roden, Clinical Research Scientist. Mr. Roden earned an M.S. in Pharmacology from the University of Miami, Florida. He previously worked as a research assistant in the clinical studies of multiple assays, including in vivo microdialysis, cell isolation, tissue preparation, radioligand binding assays, and protein quantification.
Verrity Gershin, Corporate Secretary. Ms. Gershin will graduate from the University of New Mexico with a B.U.S. degree in May, 2008. With 11 years of experience in accounting, corporate filings, and corporate administrative support, she has worked with Biomoda for the last six years, helping the company file for public status and maintaining compliance with the Securities and Exchange Commission.
Stephen Gomez, Senior Research Specialist. Dr. Gomez earned his Masters of Biology and Ph.D. in Molecular, Cell and Development Biology at the University of California. He also holds a bachelors degree in Biology from the California Institute of Technology, Pasadena. Dr. Gomez most recently worked as an associate research scientist at Lovelace Respiratory Research Institute in Albuquerque. He was previously an instructor in Genetics at the University of New Mexico, and consultant to national laboratories, including UCLA. With extensive experience with membrane proteins involved in photosynthesis, Dr. Gomez is the author of nearly a dozen publications on proteomics, including his dissertation on pigment-binding proteins while at the University of California, Los Angeles.
Herbert L. Whitaker, Director. Dr. Whitaker has a Ph.D. from Virginia Polytechnic Institute; has worked for large corporations such as General Electric and Johnson & Johnson; and has been an independent consultant. He has thirty-five years experience, with twenty-five of those years in the medical products industry. He started as a chemical engineer and progressed to his role as business executive. He was President & CEO of Lovelace Scientific Resources, a site management organization for clinical trials in Albuquerque New Mexico. He has worked for several biotech startups
|
